| 000 | 01479 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513214348.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a1434-6621 | ||
| 024 | 7 |
_a10.1515/CCLM.2000.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSena, A | |
| 245 | 0 | 0 |
_aInterferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis. _h[electronic resource] |
| 260 |
_bClinical chemistry and laboratory medicine _cMar 2000 |
||
| 300 |
_a209-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 | _aLipoproteins, HDL2 |
| 650 | 0 | 4 | _aLipoproteins, HDL3 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPedrosa, R | |
| 700 | 1 | _aFerret-Sena, V | |
| 700 | 1 | _aAlmeida, R | |
| 700 | 1 | _aAndrade, M L | |
| 700 | 1 | _aMorais, M G | |
| 700 | 1 | _aCouderc, R | |
| 773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 38 _gno. 3 _gp. 209-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2000.030 _zAvailable from publisher's website |
| 999 |
_c10855931 _d10855931 |
||